BioSpace News Archive

Apollo Endosurgery, Inc., a global leader in less invasive medical devices for gastrointestinal and bariatric procedures announced that it will participate in the H.C. Wainwright Bioconnect 2021 Conference taking place virtually January 11-14, 2021.

One of the recent developments in the biotechnology market comprises the development of a promising solution to the problem of unwanted genetic changes associated with CRISPR-Cas9.

A notable uptick in bioterrorism attack is slated to boost biodefense market size following the influence of biological agents, including Ebola, anthrax, fever viruses, smallpox, and plague.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present at four upcoming virtual conferences in January.

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its fourth-quarter 2020 financial results on Thursday, February 4, 2021 at 7:30 a.m. Central Time

Revelation Biosciences Inc. (Revelation), a clinical stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease, announced today the closing of a non-brokered private placement financing, raising gross proceeds of $9.1 million. The financing was led by Global Health Investment Advisors. The Company sold 628,930 shares of Series A Preferred Stock and

According to the European Medicines Agency reports, 2017 witnessed about 200,000 fatalities recorded from preventable safety issues with drugs.

The latest business intelligence report on ‘global immunoprotein diagnostic testing market’ uncovers the ins and outs of this business sphere with respect to the current and past business landscape.

Intra-Cellular Therapies, Inc. announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 9:10 am ET.

Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will participate in a virtual presentation at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021, at 11:40 a.m. Eastern Time.